FDA strengthens warnings to decrease the risk of serious allergic reactions with anemia drug Feraheme

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

The U.S. Food and Drug Administration (FDA) is strengthening an existing warning that serious, potentially fatal allergic reactions can occur with the anemia drug Feraheme (ferumoxytol). The FDA changed the prescribing instructions and approved a Boxed Warning, FDA’s strongest type of warning, regarding these serious risks. Via Food and Drug Administration. Posted March 30, 2015.

–Alanna McCatty


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

The Vitamins and Minerals to Boost Your Immune System

The Vitamins and Minerals to Boost Your Immune System

As we re-enter the world after months of self-isolating, is there going to be another spike in COVID-19 infections? Perhaps. However, as you increase your contact with more people, having a strong immune system is a key part of keeping healthy. To boost your immune system, make sure you are getting…

  • Advertisement